Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference May 13, 2026 04:05PM
RBC on WAVE Life Sciences (WVE): 'we continue to like the setup' Apr 28, 2026 02:58PM
RBC on WAVE Life Sciences (WVE): 't we continue to see a molecule that is pharmacologically active and remain optimistic' Mar 27, 2026 05:04AM
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns' Mar 18, 2026 09:21AM
RBC Capital Upgrades WAVE Life Sciences (WVE) to Outperform Dec 9, 2025 12:53AM


Oct 21, 2024 06:46AM WAVE Life Sciences (WVE) PT Raised to $15 at RBC Capital
May 7, 2024 08:30AM Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
Mar 6, 2024 04:18PM RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'
May 10, 2022 08:30AM Wave Life Sciences to Present at Upcoming Investor Conferences
May 10, 2022 08:30AM Wave Life Sciences to Present at Upcoming Investor Conferences
May 10, 2021 04:05PM Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
May 10, 2021 04:05PM Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
Mar 23, 2021 06:22AM Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued
Feb 6, 2017 07:30AM WAVE Life Sciences to Present at Upcoming Investor Conferences